For research use only. Not for therapeutic Use.
Miconazole(Cat No.:A000799)is an antifungal agent widely used to treat various fungal infections, including dermatophyte infections, candidiasis, and systemic mycoses. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and causing fungal cell death. Miconazole is effective against a broad spectrum of fungi and is available in topical, oral, and intravenous formulations. It is commonly prescribed for skin and mucosal infections, as well as for more severe systemic fungal infections in immunocompromised patients.
Catalog Number | A000799 |
CAS Number | 22916-47-8 |
Synonyms | 22916-47-8; Monistat; Monistat IV; Daktarin IV; Miconazolo |
Molecular Formula | C18H14Cl4N2O |
Purity | ≥95% |
Target | Fungal |
Storage | -20°C |
IUPAC Name | 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole |
InChI | InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2 |
InChIKey | BYBLEWFAAKGYCD-UHFFFAOYSA-N |
SMILES | C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl |
Reference | 1: Lozano R, Frutos A. Time course of the drug-drug interaction of 2: Simmons KB, Kumar N, Plagianos M, Roberts K, Hoskin E, Han L, Alami M, Creasy 3: Kenechukwu FC, Attama AA, Ibezim EC, Nnamani PO, Umeyor CE, Uronnachi EM, Gugu 4: Ashtarinezhad A, Panahyab A, Mohamadzadehasl B, Shirazi FH. Characterization 5: Gyanfosu L, Koffuor GA, Kyei S, Ababio-Danso B, Peprah-Donkor K, Nyansah WB, 6: Kenechukwu FC, Attama AA, Ibezim EC. Novel solidified reverse micellar 7: Pyo SM, Hespeler D, Keck CM, Müller RH. Dermal miconazole nitrate nanocrystals 8: Du Y, Luo L, Sun S, Jiang Z, Guo X. Enantioselective separation and 9: Nave R, Klein S, Müller A, Chang X, Höchel J. Absence of Effect of 10: Saboo S, Taylor LS. Water-induced phase separation of miconazole-poly |